… for COVID-19 exists. We conducted a prospective single-arm open-label phase II clinical
trial … the safety and efficacy of convalescent plasma in hospitalized patients with COVID-19. …

… ), and reduction of C-reactive protein levels (16/19) [8]. These results prompted a … On March
19th, 2020 during the ascending phase of the Italian breakout, we launched the TOCIVID-19 …

… We performed a prospective cohort study of patients with COVID-19 admitted to general …
biomarkers in potential important pathways of COVID-19 infection (inflammation, tissue damage, …

… a large prospective cohort of patients, if COVID-19 severity could have effects on endothelial
function, measured by flow-mediated dilation (FMD), in the convalescent phase of disease. …

… factors for severe COVID-19 among a prospective cohort of children and adults admitted
to a national COVID-19 treatment unit in Uganda during the first two phases of the epidemic. …

… prior to COVID-19 that would enable longitudinal assessment of impact of COVID-19; however…
acute COVID-19 and stress the importance of preventative strategies to mitigate spread of …

… patients with COVID-19. The study included 50 hospitalized symptomatic COVID-19 patients
… cytokine storm of COVID-19, thus bearing great promise for COVID-19 patients, particularly …

… with mild to moderate COVID-19 with the monoclonal antibody … Phase-II study performed
with 577 mild/moderate COVID-19 … with a high risk of developing severe COVID-19. Also, the …

… Coronavirus disease-2019 (COVID-19) are lacking. The aims of this study were to investigate
whether COVID-19 … the Emergency Department (ED) for COVID-19, and evaluated at post-…

… COVID-19 Cohort (IMPACC) is a prospective longitudinal study designed to enroll 1000
hospitalized patients with COVID-19 (… , and genomic features of COVID-19–related susceptibility, …